Comments on "Importance of Normalization of CA19-9 Levels After Neoadjuvant Therapy in Patients With Localized Pancreatic Cancer''

被引：0
|
作者：
Xu, Hua-Xiang [1 ,2 ,3 ,4 ]
Li, Shuo [1 ,2 ,3 ]
Xu, Shuai-Shuai [1 ,2 ,3 ,4 ]
Liu, Liang [1 ,2 ,3 ,4 ]
Yu, Xian-Jun [1 ,2 ,3 ,4 ]
机构：
[1] Fudan Univ, Shanghai Canc Ctr, Dept Pancreat Surg, Shanghai, Peoples R China
[2] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China
[3] Shanghai Pancreat Canc Inst, Shanghai, Peoples R China
[4] Fudan Univ, Pancreat Canc Inst, Shanghai, Peoples R China
来源：
ANNALS OF SURGERY | 2021年 / 274卷 / 06期
关键词：
RESECTION;
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：E800 / E801
页数：2
相关论文
共 50 条
  • [41] Dynamics of Serum CA19-9 in Patients Undergoing Pancreatic Cancer Resection
    van Oosten, A. Floortje
    Groot, Vincent P.
    Dorland, Galina
    Burkhart, R. A.
    Wolfgang, Christopher L.
    van Santvoort, Hjalmar C.
    He, Jin
    Molenaar, I. Quintus
    Daamen, Lois A.
    ANNALS OF SURGERY, 2024, 279 (03) : 493 - 500
  • [42] CA 19-9 Normalization Following Neoadjuvant Therapy and Yield of Laparoscopy for Pancreatic Ductal Adenocarcinoma
    Fields, Brittany C.
    Vreeland, Tim
    Newhook, Timpthy E.
    Snyder, Rebecca A.
    Maxwell, Jessica E.
    Prakash, Laura R.
    Kim, Michael
    Ikoma, Naruhiko
    Lee, Jeffrey E.
    Katz, Matthew H. G.
    Tzeng, Ching-Wei D.
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (01) : S63 - S64
  • [43] Assessment of Serum Neopterin, TPS and CA19-9 Levels in Patients With Pancreatic Adenocarcinoma
    Talar-Wojnarowska, R.
    Gasiorowska, A.
    Olakowski, M.
    Lekstan, A.
    Lampe, P.
    Smolarz, B.
    Romanowicz-Makowska, H.
    Kulig, A.
    Malecka-Panas, E.
    PANCREAS, 2009, 38 (08) : 1054 - 1055
  • [44] CA19-9 Benefits Prognostication of Pancreatic Cancer: Is It Time to Add CA19-9 to Its Staging Criteria?
    Gao, Xiang
    In, Haejin
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (08) : 4839 - 4840
  • [45] Adjusting CA19-9 for biliary obstruction in pancreatic cancer
    Bliss, Lindsay A.
    Pleskow, Douglas K.
    Eskander, Mariam F.
    Yang, Catherine J.
    Miksad, Rebecca A.
    Ng, Sing Chau
    Berzin, Tyler M.
    Sawhney, Mandeep S.
    Chuttani, Ram
    Tseng, Jennifer F.
    CANCER RESEARCH, 2015, 75
  • [46] CA19-9 decorated mucin proteins in pancreatic cancer
    Rothermund-Franklin, Christy A.
    Caffrey, Thomas C.
    Hollingsworth, Michael A.
    CANCER BIOMARKERS, 2008, 4 (03) : 160 - 160
  • [47] Serum CA19-9 determination in the management of pancreatic cancer
    vandenBosch, RP
    vanEijck, CHJ
    Mulder, PGH
    Jeekel, J
    HEPATO-GASTROENTEROLOGY, 1996, 43 (09) : 710 - 713
  • [48] CA19-9 serum levels predict micrometastases in patients with gastric cancer
    Jagric, Tomaz
    Potrc, Stojan
    Mis, Katarina
    Plankl, Mojca
    Mars, Tomaz
    RADIOLOGY AND ONCOLOGY, 2016, 50 (02) : 204 - 211
  • [49] ASO Author Reflections: Does Adjuvant Therapy Confer a Survival Benefit in Patients Receiving Neoadjuvant Chemotherapy for Pancreatic Cancer? A CA19-9 Analysis
    Hao Liu
    Amer Zureikat
    Annals of Surgical Oncology, 2020, 27 : 3961 - 3962
  • [50] ASO Author Reflections: Does Adjuvant Therapy Confer a Survival Benefit in Patients Receiving Neoadjuvant Chemotherapy for Pancreatic Cancer? A CA19-9 Analysis
    Liu, Hao
    Zureikat, Amer
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (10) : 3961 - 3962
12345